Abstract:AbstractThe deleted in liver cancer 2 (DLC2) is a tumor suppressor gene, frequently found to be underexpressed in hepatocellular carcinoma. DLC2 is a multidomain protein containing a sterile α‐motif (SAM) domain, a GTPase‐activating protein (GAP) domain, and a lipid‐binding StAR‐related lipid‐transfer (START) domain. The SAM domain of DLC2, DLC2‐SAM, exhibits a low level of sequence homology (15–30%) with other SAM domains, and appears to be the prototype of a new subfamily of SAM domains found in DLC2‐related proteins. In the present study, we have determined the three‐dimensional solution structure of DLC2‐SAM using NMR methods together with molecular dynamics simulated annealing. In addition, we performed a backbone dynamics study. The DLC2‐SAM packed as a unique four α‐helical bundle stabilized by interhelix hydrophobic interactions. The arrangement of the four helices is distinct from all other known SAM domains. In contrast to some members of the SAM domain family which form either dimers or oligomers, both biochemical analyses and rotational correlation time (τc) measured by backbone 15N relaxation experiments indicated that DLC2‐SAM exists as a monomer in solution. The interaction of DLC2‐SAM domain with sodium dodecyl sulfate (SDS) micelles and 1,2‐dimyristoyl‐sn‐glycerol‐3‐phosphatidylglycerol (DMPG) phospholipids was examined by CD and NMR spectroscopic techniques. The DLC2‐SAM exhibits membrane binding properties accompanied by minor loss of the secondary structure of the protein. Deletion studies showed that the self‐association of DLC2 in vivo does not require SAM domain, instead, a protein domain consisting of residues 120–672 mediates the self‐association of DLC2. Proteins 2007. © 2007 Wiley‐Liss, Inc.

Solution Structure Of Tensin2 Sh2 Domain And Its Phosphotyrosine-Independent Interaction With Dlc-1

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

The Structure of the Tiam1 PDZ Domain/ Phospho-Syndecan1 Complex Reveals a Ligand Conformation That Modulates Protein Dynamics.

Solution Structures, Dynamics, and Lipid‐binding of the Sterile Α‐motif Domain of the Deleted in Liver Cancer 2

Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet

Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect

Pentameric Assembly of the Kv2.1 Tetramerization Domain

DLC1 SAM Domain-Binding Peptides Inhibit Cancer Cell Growth and Migration by Inactivating RhoA

SH2 Domain, an Important Phosphotyrosine-Binding Domain

Crystal Structure of Human Dynein Light Chain Dnlc2A: Structural Insights into the Interaction with IC74.

Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study

Structural insights into selective interaction between type IIa receptor protein tyrosine phosphatases and Liprin-α

Structural Investigation of the Interaction Between the Tandem SH3 Domains of C-Cbl-associated Protein and Vinculin.

Antagonism Between Binding Site Affinity and Conformational Dynamics Tunes Alternative Cis-Interactions Within Shp2.

Dissecting phospho-motif-dependent Shc1 interactome using long synthetic protein fragments

Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.

Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain.

Structural basis of diverse sequence-dependent target recognition by the 8 kDa dynein light chain

Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1

Study of SHP-2 (PTPN11) Allosterism on Structural Movement Using Solution Perturbed Molecular Dynamics Simulation

Loops Govern SH2 Domain Specificity by Controlling Access to Binding Pockets